ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
์ข
๋ชฉ ์ฝ๋ RSLS
ํ์ฌ ์ด๋ฆReShape Lifesciences Inc
์์ฅ์ผOct 06, 2016
CEOMr. Paul F. Hickey
์ง์ ์17
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃOct 06
์ฃผ์1001 Calle Amanecer
๋์SAN CLEMENTE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ Capital Market Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ92673
์ ํ19494296680
์น์ฌ์ดํธhttps://www.reshapelifesciences.com/obalon/
์ข
๋ชฉ ์ฝ๋ RSLS
์์ฅ์ผOct 06, 2016
CEOMr. Paul F. Hickey
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์